Healthcare -
Biotechnology - NASDAQ - US
$ 0.9299
-8.83 %
$ 108 M
Market Cap
3.72
P/E
CHRS - REVENUE
Revenue CHRS - Coherus BioSciences, Inc.
267 M
LAST VALUE
12.47%
2 YEAR CAGR
-5.60%
5 YEAR CAGR
23.98%
10 YEAR CAGR